 |
|
Home | Weekly Investment Analysts’ Ratings Changes for Achillion Pharmaceuticals (ACHN) |
 |
Weekly Investment Analysts’ Ratings Changes for Achillion Pharmaceuticals (ACHN)
|
 |
- January 01, 2015
-
A number of stock research firms have changed their ratings and price targets for Achillion Pharmaceuticals (NASDAQ: ACHN) during the last seven days: Achillion Pharmaceuticals had its price target raised by analysts at Deutsche Bank from $17.00 to $25.00. They now have a “buy” rating on the stock. Achillion Pharmaceuticals was given a new $22.00 […]This article (Weekly Investment Analysts’ Ratings Changes for Achillion Pharmaceuticals (ACHN)) was originally developed by and is property of American Banking News.
Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.
- Read more at:http://www.americanbankingnews.com/2014/12/31/weekly-investment-analysts-ratings-changes-for-achillion-pharmaceuticals-achn/
|
 |
|
 |
|
 |
